BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:In 2023\, industry is witnessing a renaissance in viral vector
  characterization. Spurred by widespread biopharma investment to engineer
  a new wave of novel capsids and faced with newly launched QbD frameworks
  by US Pharmacopeia and the FDA’s tightened guidance\, increased vector c
 omplexity is creating a new era for advanced analytical technologies to e
 nsure precision and accuracy.\n\nIn the wake of significant collaboration
 s including Vector Bio and iBET’s for high-throughput characterization\, 
 and the likes of Vertex and BMS announcing their priority to build out th
 eir internal analytical competencies\, the inaugural Viral Vector Charact
 erization &amp\; Analytical Development Summit arrives to pave the founda
 tion for teams to further optimize process development and accelerate vec
 tor scale-up with GMP compliance in mind.\n\nUniting Characterization\, A
 nalytical\, Formulation\, Quality\, Engineering\, CMC and Process leaders
 \, this industry-led summit is your only for cross-learning opportunities
  across AAV’s\, LV’s &amp\; RV’s and more – so you can benchmark your wor
 k against rapid-analytical method development transforming your peers’ wo
 rkflows\, turnaround\, and consistency.\n\nStay ahead of the curve\, and 
 join the likes of Ultragenyx\, Kite Pharma\, BioMarin\, Neogene Therapeut
 ics\, Pfizer and many more for a 3-day jam packed agenda\, set to tackle 
 your biggest bottlenecks.\n
DTEND:20230927T160000
DTSTAMP:20260512T223114Z
DTSTART:20230925T100000
LOCATION:Hilton Boston/Woburn\, 2 Forbes Road\, Woburn\, Massachusetts\, 0
 1801\,
SEQUENCE:0
SUMMARY:In 2023\, industry is witnessing a renaissance in viral vector cha
 racterization. Spurred by widespread biopharma investment to engineer a n
 ew wave o...
UID:60ea3d44-7e54-440d-ac59-43af8f76dd7a
END:VEVENT
END:VCALENDAR